Same Indication

Losartan vs Nivolumab

Losartan vs Nivolumab: Overview

This comparison examines the pharmacological differences between Losartan and Nivolumab.

Mechanism of Action

Losartan: Angiotensin II receptor type 1 antagonist.

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Pharmacokinetics

Half-life: Losartan — 2 hours; Nivolumab — 27 days.

Chemical Properties

Molecular Formula: Losartan — C22H23ClN6O.

Molecular Weight: Losartan — 422.9200 g/mol.

Type: Losartan — Small molecule; Nivolumab — Antibody.